Oncology

  1. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €7,350.00
  2. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €3,657.00
  3. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,374.25
  4. Beleodaq (belinostat)
    Beleodaq (belinostat)
    by Spectrum Pharmaceuticals, Inc.
    for Lymphoma
    €3,162.50
  5. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €16,847.50
  6. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €3,047.50
  7. Cabometyx (cabozantinib)
    Cabometyx (cabozantinib)
    by Ipsen Pharma
    for Kidney Cancer
    €6,279.00
  8. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
    €5,629.25
  9. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
    €5,692.50
View as Grid List

Items 1-9 of 31

Page
per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE